HRS23 Announces Late-breaking Clinical Trials and Science Sessions

Heart Rhythm 2023, the society's 44th annual meeting, takes place May 19-21, in New Orleans

Related Keywords

,Collaborative Group ,Efficacy Of Low Energy Multi ,Chamber Leadless Cardiac Pacemaker System ,Collaborative Study Group ,A Prospective Left Bundle Branch Pacing Study ,Heart Rhythm Society ,Energy Multi ,Heart Rhythm ,Breaking Randomized Clinical Trials ,Breaking Clinical Innovations ,Breaking Clinical Trial Updates ,Breaking Science ,Weight Loss ,Atrial Fibrillation Ablation Outcome ,Liraglutide Effect ,Atrial Fibrillation ,Clinical Outcomes ,Pulsed Field Ablation ,Treat Patients ,Paroxysmal Atrial ,Wide Experience ,End Hole Irrigated Needle Catheter ,Refractory Ventricular Arrhythmias ,Atrial Arrhythmia Burden ,Patients Undergoing Pulsed Field Ablation ,Non Ischemic Cardiomyopathy Patients ,Implanted Defibrillator ,Cardiac Resynchronization ,Implantable Cardioverter Defibrillator Leads ,Tricuspid Valve ,Right Ventricle ,Prospective Phase ,Term Prediction ,Life Threatening Ventricular Arrhythmias ,Postoperative Atrial Fibrillation ,Calcium Mediated Autonomic Denervation ,Data Driven Management ,Real World Outcomes ,Energy Multi Pulse Therapy ,Dual Chamber Leadless Cardiac Pacemaker System ,Bidirectional Communication ,Human Clinical Feasibility Study ,Evaluate Safety ,Low Energy Multi Pulse Therapy ,Support Device ,High Risk Patients ,Advanced Heart Failure Undergoing ,Vagus Nerve Stimulation ,Postural Tachycardia Syndrome ,Randomized Clinical ,Prospective Validation ,Defibrillation Test Success ,Conduction System Pacing Optimized Trial ,Randomized Controlled Clinical Trial ,Resonance Imaging Based ,Lead Cardiac Resynchronization Therapy ,Prospective Left Bundle Branch Pacing Study ,Results From International ,Universal Remote Monitoring Platform ,Large Real World ,Initial Implant Strategy ,Cardiac Resynchronization Therapy ,Heart Failure ,